Safety and Efficacy Study of the BioVentrix PliCath HF System (CONFIGURE-HF)
Phase II Study of the BioVentrix PliCath HF™ System for the Treatment of Ischemic Cardiomyopathy
Sponsor: Advance Research Associates
A NA clinical study on Heart Failure, this trial is completed. The trial is conducted by Advance Research Associates and has accumulated 10 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Dec 2025 — Present [monthly]
Completed NA
-
Sep 2025 — Dec 2025 [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2021 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
▶ Show 5 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Unknown Status NA
-
Oct 2018 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Advance Research Associates
- BioVentrix
- CDI Centro Diagnostico Italiano S.p.A
- Ohio State University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Athens, Greece , Barcelona, Spain , Bordeaux, France , Brescia, Italy , Innsbruck, Austria , Katowice, Poland , Krakow, Poland , London, United Kingdom , Milan, Italy , Padua, Italy and 7 more locations